A multicenter case-control study for early detection of psoriatic arthritis using ultrasonography and easy-to-use questionnaires in psoriasis patients in the outpatient dermatology clinic

Recruiting

• Conditions: Psoriasis; chronich skin inflammation with joint inflammation; 10003816; psoriatic arthritis; 10014982

• Registration Number: NL-OMON46760
• Lead Sponsor: Maasstadziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

* Patients that are diagnosed with psoriasis by their dermatologist
* be able to read/write the Dutch language
* provide a written informed consent
* age > 18 years

Exclusion Criteria

- Patients who already have the diagnosis of PsA according to a rheumatologist
- Patients using conventional disease-modifying antirheumatic drugs (DMARDs) or biological DMARDs such as TNF-, IL-17A or IL-23 inhibitors.
* Patients using cyclosporin or tacrolimus.
* Patients using systemic corticosteroids.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The sensitivity and specificity of the PEST-questionnaire and ultrasonography<br /><br>in identifying PsO patients having PsA according to a rheumatologist and meet<br /><br>the CASPAR-criteria. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Quality of life and physical functioning after 1 year after screening</p><br>